Keyphrases
10-year Mortality
26%
Acute Myocardial Infarction Model
26%
Admission Blood Glucose
26%
Arrhythmia Recurrence
26%
Atrial Arrhythmia
26%
Atrial Fibrillation
44%
Atrial Fibrillation Recurrence
46%
Atrial Fibrillation Type
26%
Atrial Undersensing
26%
Cardiac Implantable Electronic Device Infection
26%
Cardioverter-defibrillator Implantation
52%
Clinical Experience
26%
Clinical Outcomes
30%
Cryoablation
32%
Dabigatran
52%
Debridement
26%
Device Replacement
26%
Epicardial Fat
26%
Erythropoietin
26%
Fibrous Capsule
26%
Generator Replacement
26%
Gestational Diabetes Mellitus
26%
Heart Failure
26%
High Dose
31%
Implantable Defibrillator
78%
Implantable Loop Recorder
26%
Infection Risk
26%
Inflammatory Markers
26%
Israeli
26%
Left Ventricular End-diastolic Diameter
26%
Left Ventricular Function
39%
Life-threatening Arrhythmias
26%
Lipomatosis
26%
Magnetic Resonance Guidance
26%
Medical Center
36%
Myocardial Infarction
52%
Pacemaker Implantation
26%
Permanent Pacemaker
52%
Permanent Pacemaker Implantation
32%
Platelet Reactivity
26%
Pulmonary Vein Isolation
32%
Rivaroxaban
26%
Sick Sinus Syndrome
26%
Sinus Node Dysfunction
26%
Sinus Rhythm
26%
Syncope
26%
Transcatheter
26%
Transcatheter Aortic Valve Implantation
45%
Transcatheter Aortic Valve Replacement
26%
Ventricular Arrhythmia
32%
Medicine and Dentistry
Acute Heart Infarction
26%
Apoplexy
38%
Atrial Fibrillation
100%
Atrioventricular Block
15%
Cardiac Computed Tomography
13%
Cardiac Dysrhythmia
46%
Cardiac Resynchronization Therapy
14%
Cardiovascular System
26%
Catheter Ablation
18%
Catheter Navigation
13%
Chest Radiograph
13%
Computed Tomography Studies
26%
Cryoablation
30%
Dabigatran
26%
Debridement
26%
Defibrillator
35%
Device Infection
26%
Drug Megadose
43%
Elderly Patient
15%
Endocardium
26%
Epicardial Fat
26%
Erythropoietin
26%
Gadolinium
16%
Heart Left Ventricle Function
26%
Heart Ventricle Arrhythmia
32%
Implantable Automatic Defibrillator
78%
Infarction
28%
Ischemic Cardiomyopathy
26%
Lipomatosis
26%
Low Drug Dose
26%
Multivariate Analysis
16%
Myocardial Infarction
46%
Nuclear Magnetic Resonance
52%
Observational Study
26%
Pacemaker Implantation
43%
Percutaneous Aortic Valve Replacement
64%
Pericardial Fat
13%
Permanent Pacemaker
52%
Primary Prevention
29%
Pulmonary Vein Isolation
35%
Recurrent Disease
52%
Scar Tissue
26%
Serum Albumin
21%
Sick Sinus Syndrome
26%
Sinus Node Disease
26%
Sinus Rhythm
35%
Sudden Cardiac Death
26%
Tachyarrhythmia
39%
Ventricular Tachycardia
16%
Warfarin
26%